Clinical Trial Update: A Study Of Panobinostat In Children With Refractory Hematologic Malignancies [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 pediatric study evaluating panobinostat in children with refractory hematologic malignancies, including acute ly…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Panobinostat (Panobinostat)

Snippet

Sponsor: Therapeutic Advances in Childhood Leukemia Consortium | Conditions: Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood | Phase 1 | Status: COMPLETED